FINNENCE ▪ THE WIRE FILE
THE WIRE · № 90296
News■ Mixed
As Reliance Jio eyes listing, what are India's biggest share offerings?
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
THE MACHINE IS STILL READING THIS ITEM — ANALYSIS LANDS WITHIN MINUTES OF INGESTION.
FULL DISPATCH
As Reliance Jio eyes listing, what are India's biggest share offerings? Reuters
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
CONTEXTIndia
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares India
Billionaire Mukesh Ambani's Jio launches India's biggest share sale2026-10-21 05:16 UTC
Billionaire Mukesh Ambani's Jio launches India's biggest share sale2026-10-21 05:16 UTC
→CORRELATIONshares India
24 million barrels a day: Gulf oil flows surge past prewar levels despite US-Iran war2026-10-21 04:58 UTC
24 million barrels a day: Gulf oil flows surge past prewar levels despite US-Iran war2026-10-21 04:58 UTC
→CORRELATIONshares India
Public bidding for the $3.2 billion IPO of Jio Platforms opens on October 21, testing the appetite for India's largest share sale to date and the first from billionaire Mukesh Ambani's Reliance conglomerate in two decades. More here:2026-10-21 01:27 UTC
Public bidding for the $3.2 billion IPO of Jio Platforms opens on October 21, testing the appetite for India's largest share sale to date and the first from billionaire Mukesh Ambani's Reliance conglomerate in two decades. More here:2026-10-21 01:27 UTC
→CORRELATIONshares India
State Bank of India reported a cyberattack that resulted in the disclosure of 3,897 customer records containing personally identifiable information on the dark web. More here:2026-10-21 05:40 UTC
State Bank of India reported a cyberattack that resulted in the disclosure of 3,897 customer records containing personally identifiable information on the dark web. More here:2026-10-21 05:40 UTC
←CORRELATIONshares India
Sun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patients Who Are Not Candidates for Curative Surgery or Curative Radiation2026-10-20 16:51 UTC
Sun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patients Who Are Not Candidates for Curative Surgery or Curative Radiation2026-10-20 16:51 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.